RhumbLine Advisers’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-23,314
Closed -$42K 3027
2017
Q1
$42K Buy
23,314
+6,980
+43% +$39.2K ﹤0.01% 2829
2016
Q4
$125K Sell
16,334
-2,544
-13% -$46.8K ﹤0.01% 2771
2016
Q3
$813K Buy
18,878
+5,035
+36% +$227K ﹤0.01% 1935
2016
Q2
$715K Buy
13,843
+4,726
+52% +$283K ﹤0.01% 1982
2016
Q1
$506K Buy
9,117
+2,885
+46% +$149K ﹤0.01% 2212
2015
Q4
$340K Buy
6,232
+478
+8% +$30.5K ﹤0.01% 2497
2015
Q3
$465K Buy
5,754
+179
+3% +$18.5K ﹤0.01% 2274
2015
Q2
$530K Buy
5,575
+685
+14% +$47.1K ﹤0.01% 2288
2015
Q1
$246K Buy
+4,890
New +$193K ﹤0.01% 2726

Other funds holding ADPT

RhumbLine Advisers's ADPT Position: Q2 2017 in Review

RhumbLine Advisers sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 23,314 shares — an estimated $42K sold.

RhumbLine Advisers first reported a position in ADPT in Q1 2015 and held it in 9 quarters. The position peaked at $813K in Q3 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • RhumbLine Advisers reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • RhumbLine Advisers sold 23,314 Adeptus Health Inc shares in Q2 2017, an estimated $42K.
  • RhumbLine Advisers first reported a position in Adeptus Health Inc in Q1 2015 and held it in 9 quarters.
  • RhumbLine Advisers's Adeptus Health Inc position peaked at $813K in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.